Incyte Corp. (INCY)
100.50
+0.04
(+0.04%)
USD |
NASDAQ |
Dec 05, 10:21
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 19.73B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 34.63% |
| Valuation | |
| PE Ratio | 16.86 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 4.154 |
| Price to Book Value | 4.242 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.0089 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 58.51% |
Profile
| Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE. |
| URL | http://www.incyte.com |
| Investor Relations URL | https://investor.incyte.com/ |
| HQ State/Province | Delaware |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Feb. 09, 2026 (est.) |
| Last Earnings Release | Oct. 28, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE. |
| URL | http://www.incyte.com |
| Investor Relations URL | https://investor.incyte.com/ |
| HQ State/Province | Delaware |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Feb. 09, 2026 (est.) |
| Last Earnings Release | Oct. 28, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |